Medpace
MEDP
250 hedge funds and large institutions have $2.43B invested in Medpace in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 87 increasing their positions, 94 reducing their positions, and 38 closing their positions.
1% more capital invested
Capital invested by funds: $2.42B → $2.43B (+$14.4M)
0.39% less ownership
Funds ownership: 80.88% → 80.49% (-0.39%)
7% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 94
7% less funds holding
Funds holding: 268 → 250 (-18)
25% less call options, than puts
Call options by funds: $4.03M | Put options by funds: $5.39M
29% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$30.9M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$22M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$21.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$17.2M |
| 5 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$49.3M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$18.5M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$8.94M |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$8.51M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.12M |
MEDP Hedge Fund Activity: Q4 2019 in Review
250 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2019, worth a combined $2.43B — up 0.6% from $2.42B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of MEDP and 27 opened new positions — a net loss of 11 holders — while 94 trimmed existing stakes and 87 added.
The largest buyer was Wasatch Advisors, adding an estimated $30.9M. The largest seller was Acadian Asset Management, cutting an estimated $49.3M.
- 250 institutional investors held Medpace (MEDP) as of Q4 2019, down from 268 in Q3 2019.
- Funds reported $2.43B of Medpace stock for Q4 2019, up 0.6% quarter-over-quarter.
- 27 funds opened new Medpace positions in Q4 2019 and 38 closed out, a net change of -11 holders.
- The largest Medpace buyer in Q4 2019 was Wasatch Advisors, an estimated $30.9M added.
- The largest Medpace seller in Q4 2019 was Acadian Asset Management, an estimated $49.3M sold.
Based on aggregated 13F filings for Q4 2019.